Rob Stein

During an online forum sponsored by Harvard, Dr. Anthony Fauci discusses how his high-profile position has affected his family personally.

The coronavirus outbreak is getting worse in many parts of the country, and the U.S. will likely need to learn to cope with having the virus be a part of life for many more months.

The National Institutes of Health is giving $248.7 million dollars to seven companies developing new technologies for testing, including use of the revolutionary gene-editing technique CRISPR.

With the coronavirus spreading out of control in many parts of the U.S., some experts say the strategy of testing and tracing can't contain the pandemic until lockdowns bring case numbers down.

The first gene therapy for hemophilia could be approved by the FDA within six months, according to the drugmaker, raising hopes among families. But the drug's price could be $3 million per patient.

Why is the US suffering such a shortage of testing? The Trump administration is promising to perform 100 million tests by September. Is that realistic?

Doctors are using a new antigen test that is a faster method to spot people infected with the coronavirus. It's cheaper and simpler but may be less reliable.

A new NPR/Harvard analysis finds most states' testing efforts still fall far short of what's needed to beat back the pandemic. Find out how your state is doing.

Since receiving a landmark treatment with the gene-editing tool CRISPR, a sickle cell patient has the strength to care for herself and her children — while navigating the pandemic.

The program shipping swabs and other supplies to labs is one of the Trump administration's efforts to ensure sufficient coronavirus testing. But some of these supplies have turned out to be hazardous.

New coronavirus hot spots are emerging around the country, and many public health experts say the U.S, is still falling short on having enough testing and contract tracing to contain the virus.

New cases are rising in at least 20 states, even as restrictions on daily life continue to ease. The U.S. total represents more than 25% of the confirmed cases worldwide.

Troubling signs are emerging that new coronavirus hot spots may have started to erupt around the United States as the country has begun to reopen.

The federal government says that as of Aug. 1, all laboratories must include detailed demographic data when reporting test results in order to help fight the pandemic nationally.

Protests over George Floyd's death continue sweeping across the U.S., creating new dangers. Public health experts fear the coronavirus could begin erupting in new outbreaks around the country.

CDC chief Robert Redfield says that earlier testing for the coronavirus would have been like "looking for a needle in a haystack." But other health experts dispute his assertion.

As more people get tested for antibodies to the coronavirus, fears rise that they'll let down their guard mistakenly believing antibodies guarantee protection.

The CDC combines results of a test that spots people who are actively infected with results from another one that looks for antibodies. Scientists say it could create a false picture of the pandemic.

As more and more people get tested for antibodies to the coronavirus, infectious disease specialists worry that those tested — and their employers — may not understand the limits of the results.

The Food And Drug Administration is raising concerns about the accuracy of the Abbott ID Now Coronavirus test, which returns results within 15 minutes. The FDA worries about false negative results.